Abiopharma

General Announcement: Net Tangible Assets (NTA) Per Unit

General Announcement: Net Tangible Assets (NTA) Per Unit

General Announcement: Net Tangible Assets (NTA) Per Unit

General Announcement: Net Tangible Assets (NTA) Per Unit

Communiqué de presse : Le Tzield de Sanofi approuvé aux États-Unis comme première thérapie modificatrice de la maladie pour les patients récemment diagnostiqués avec un diabète de type 1 au stade 3

Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

BORR Investors Have Opportunity to Join Borr Drilling Limited Fraud Investigation with the Schall Law Firm

UTHR: Notification

UTHR: Notification

BlackRock ESG Capital Allocation Term Trust (ECAT) Announces Certified Results of 2026 Annual Shareholder Meeting